The Valley Desk

Clinical trial reportNEJM evidencePublished

Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
NEJM evidence
Published
Subject terms
Humans; Psoriasis; Treatment Outcome; Administration, Oral; Severity of Illness Index; Double-Blind Method; Adolescent; Adult; Aged; Middle Aged; Child; Female
PubMed ID
41191932
Added to directory
Source checked

Report a correction or request removal